Skip to NavigationSkip to content

Features

Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the rounds now. The stock made a...

A recent exposé has highlighted how the quest for profits at the UK’s biggest pharmacy chain, Boots, is potentially putting the public at risk. So...

Early March, German drug major Merck and US pharma giant Pfizer (NYSE: PFE) agreed to develop a treatment for advanced ovarian cancer along with a...

Drug trial results along with licencing agreements led stock movements for drug makers and biotech firms this week

Dust settles as pharma’s biggest merger gets consigned to scrap heap

Craig Nelson, managing director and Jennifer Stein, managing director, Alsbridge, on...

A quick look at the big movers from the past week 

As far as months go, March 2016 couldn’t have gone much worse for Valeant Pharmaceuticals. The Canada-based company has been surrounded by...

Moody’s Investor Service lowered its growth outlook for the global pharma sector but maintained the mergers and acquisitions in the sector will...

It is nothing short of sunny for the small cap biotech companies, with stocks rallying as much as 400% following positive drug trial updates

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches